Sells specialty ingredients and additives to pharmaceutical, branded consumer-products, and industrial customers.
10-K for FY2025, filed Nov 20, 2025The Company serves customers in a wide range of consumer and industrial markets including, architectural coatings, construction, energy…View ↗
Life Sciences is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials)…View ↗
Personal Care is comprised of biofunctionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and…View ↗
Specialty Additives is comprised of rheology and performance-enhancing additives serving the architectural coatings, construction, energy…View ↗
Ashland sells goods under contracts or purchase orders and generally collects payment after delivery.
10-K for FY2025, filed Nov 20, 2025Ashland’s sales are measured as the amount of consideration it expects to receive in exchange for transferring goods and are recognized…View ↗
A performance obligation is deemed to be satisfied by Ashland when control of the product or service is transferred to the customer. The…View ↗
All of Ashland’s sales are derived from contracts or purchase orders with customers, and nearly all contracts or purchase orders with…View ↗
10-K for FY2025, filed Nov 20, 2025
FY2025 revenue by reportable segment ↗$1.8B
10-K for FY2025, filed Nov 20, 2025
$1.8B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Life Sciences
Sold outright
10-K for FY2025, filed Nov 20, 2025 |
35%
FY2022: 34%
|
Life Sciences, FY2025
$641M Sources
|
Sold outright |
|
Personal Care
Sold outright
10-K for FY2025, filed Nov 20, 2025 |
32%
FY2022: 28%
|
Personal Care, FY2025
$577M Sources
|
Sold outright |
|
Specialty Additives
Sold outright
10-K for FY2025, filed Nov 20, 2025 |
28%
FY2022: 30%
|
Specialty Additives, FY2025
$511M Sources
|
Sold outright |
|
Intermediates
Sold outright
|
7.5%
FY2022: 11%
|
Intermediates, FY2025
$137M Sources
|
Sold outright |
Ashland serves pharmaceutical, food and beverage manufacturers, branded consumer-product formulators, and industrial customers in coatings, construction and other markets. It markets and distributes its products across the Americas, Europe, the Middle East, Africa and Asia Pacific.
10-K for FY2025, filed Nov 20, 2025Life Sciences is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials)…View ↗
Personal Care is comprised of biofunctionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and…View ↗
Specialty Additives is comprised of rheology and performance-enhancing additives serving the architectural coatings, construction, energy…View ↗
Life Science markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.View ↗
Personal Care markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.View ↗
Specialty Additives markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.View ↗
No. It lost $845M in FY2025.
10-Q for Q3 FY2026, filed Jul 29, 2026
$16MView ↗
10-Q for Q3 FY2026, filed Jul 29, 2026
Open tableView ↗
8-K, filed Jul 28, 2026
Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 millionView ↗
8-K, filed Apr 28, 2026
Updating full‑year fiscal 2026 sales guidance to $1,835-$1,870 million and Adjusted EBITDA guidance to $385-$400 million, primarily…View ↗
8-K, filed Feb 2, 2026
Narrowing full‑year fiscal 2026 Adjusted EBITDA guidance to $400–$420 million, reflecting approximately $11 million of temporary impacts…View ↗
Shrinking. Revenue fell 14% in 4 years, from $2.1B in FY2021 to $1.8B in FY2025, about 4% a year.
Nutraceuticals sale
Life Sciences no longer includes Ashland’s nutraceuticals business: the older report described nutraceutical products and related formulation, particle-engineering and contract-manufacturing services, while the latest report says the business was sold.
10-K for FY2022, filed Nov 21, 2022 10-K for FY2025, filed Nov 20, 2025Life Sciences is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials)…View ↗
Loading...